UGT1A1 and neutropenia: In summary, this study demonstrates that UGT1A1*6 and UGT1A1*28 polymorphisms can serve as important molecular markers for predicting varying degrees of toxicity induced by IRI chemotherapy in Chinese cancer patients, particularly in predicting severe toxic events such as severe diarrhea and severe neutropenia.